Glaucoma Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Disease Indication (Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma and Other); Drug class (Prostaglandin Analogs (PGAs), Alpha Agonist, Beta Blockers, Cholinergic Drugs, Carbonic Anhydrase Inhibitors and Others); Surgery (Laser Iridotomy, Laser Trabeculoplasty, Aqueous Shunt Surgery and Peripheral Iridectomy); End Users (Hospitals, Clinics, Home Users) and Geography
The medical condition where eye's optic nerve is damaged is termed as glaucoma. The most common glaucoma condition is inherited and often may not show later in life. People with diabetes are at risk of developing this condition. If not treated on time it may lead to visual loss.
The Glaucoma market is anticipated to grow in the forecast, owing to rising geriatric population, growing prevalence of diabetes and newly developed technologies to treat glaucoma. In addition, the growing adoption of laser surgery to treat glaucoma is expected to offer significant growth opportunities in the market during the forecast period.
The "Global Glaucoma market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Glaucoma market with detailed market segmentation by disease indication, surgery, drug class, end users and geography. The global Glaucoma market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Glaucoma market players and offers key trends and opportunities in the market.
The global Glaucoma market is segmented on the basis of disease indication, surgery, drug class, end users. Based on disease indication, the market is segmented as, closed angle glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other. Based on drug class, the market is segmented in to prostaglandin analogs (PGAS), alpha agonist, beta blockers, cholinergic drugs, carbonic anhydrase inhibitors and others. Based on surgery the market is segmented into laser iridotomy, laser trabeculoplasty, aqueous shunt surgery and peripheral iridectomy. On the basis of end user, the glaucoma market is categorized as hospitals, clinics, home users.
Get more information on this report :
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Glaucoma market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Glaucoma market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Glaucoma market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Glaucoma market in these regions.
Get more information on this report :
The reports cover key developments in the Glaucoma market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Glaucoma market are anticipated to lucrative growth opportunities in the future with the rising demand for Glaucoma market in the global market. Below mentioned is the list of few companies engaged in the Glaucoma market.
The report also includes the profiles of key Glaucoma market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Merck & Co
cular Therapeutix Inc
Icon Bioscience Inc
Amorphex Therapeutics LLC.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.